Opportunity Information: Apply for PA 13 226
Apply for PA 13 226
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "Evidence based Demonstration Projects in Immunization (Admin Supp)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.307 Minority Health and Health Disparities Research.
- This funding opportunity was created on May 16, 2013 and posted on May 16, 2013.
- Applicants must submit their applications by Jul 10, 2013. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $100,000.00 in funding.
- Eligible applicants include: Native American tribal organizations (other than Federally recognized tribal governments) Public housing authorities/Indian housing authorities Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Special district governments Native American tribal governments (Federally recognized) Small businesses Others (see text field entitled Additional Information on Eligibility for clarification) Private institutions of higher education County governments City or township governments Public and State controlled institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Independent school districts State governments For profit organizations other than small businesses.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Asian American Native American Pacific Islander Serving Institutions (AANAPISISs) Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession Non domestic (non U.S.) Entities (Foreign Institutions) are not eligible to apply. Non domestic (non U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The grant opportunity "Evidence based Demonstration Projects in Immunization (Admin Supp)" (Funding Opportunity Number PA-13-226) was a discretionary NIH funding announcement led by the National Institute on Minority Health and Health Disparities (NIMHD) in partnership with the National Vaccine Program Office (NVPO) within the U.S. Department of Health and Human Services. It was structured specifically as an administrative supplement, meaning it was not a stand-alone new grant competition. Instead, it provided additional, targeted funding to investigators and institutions that already held certain active NIMHD-supported awards, allowing them to add a focused demonstration project onto an existing research or center infrastructure.
The central purpose of the supplement was to support evidence-based demonstration projects aimed at reducing infectious diseases by increasing immunization rates. The emphasis was on practical, real-world projects that use strategies with evidence behind them and that can be demonstrated in communities or healthcare settings to improve vaccination uptake. The populations of interest were health disparity populations, and the intent was to stimulate measurable improvements in immunization coverage among children, adolescents, pregnant women, and adults. In other words, the opportunity was designed to help funded NIMHD investigators translate known effective immunization approaches into implementations that address persistent vaccination gaps affecting communities that experience disproportionate burden of disease and barriers to preventive care.
Eligibility was primarily tied to having an active, relevant NIMHD award that could receive an administrative supplement. Specifically, the announcement targeted current NIMHD R01 grantees as well as awardees funded under several NIMHD center or infrastructure programs: Centers of Excellence (COE) awards using the P20 or P60 mechanisms, Research Centers in Minority Institutions (RCMI) awards using the G12 or U54 mechanisms, and the Community Based Participatory Research Initiative using the R24 mechanism. While the general grants.gov eligibility list includes many organization types (state and local governments, universities, nonprofits, small businesses, tribal entities, and others), the practical gatekeeper for this opportunity was that the applicant needed to be in the set of currently funded NIMHD projects or centers that qualified for supplementation. Foreign institutions were not eligible, foreign components were not allowed, and non-U.S. components of U.S. organizations were also not eligible, aligning with standard NIH restrictions stated in the notice.
Financially, the supplement had an award ceiling of $100,000 and did not require cost sharing or matching. The listing associated with CFDA 93.307 (Minority Health and Health Disparities Research) places it squarely within the federal portfolio supporting research and interventions to reduce health inequities. The overall category was health, and the funding instrument type was a grant. The opportunity was posted on May 16, 2013, with an application closing date of July 10, 2013, and it was archived on August 10, 2013, indicating it was a time-limited supplement initiative rather than an ongoing program.
From an implementation standpoint, the announcement signals an expectation that funded teams would leverage existing NIMHD-supported research capacity and community relationships to execute targeted immunization improvement efforts. Because it is framed as a demonstration project, the work would generally be expected to show feasibility, uptake, and practical impact in specific settings or populations, rather than purely exploratory research. The focus on "evidence-based" approaches suggests applicants were expected to select strategies already supported by research or prior successful use, then adapt and apply them to the realities of health disparity populations, including barriers such as access challenges, trust and communication gaps, system navigation difficulties, or resource limitations in certain communities.
Key administrative details included an official NIH announcement link (hosted on the NIH grants guide) and contact support routed through the NIH Office of Extramural Research (OER) webmaster for technical access and linking issues. Overall, PA-13-226 was a focused, short-window administrative supplement opportunity meant to accelerate on-the-ground immunization gains within populations experiencing health disparities by enabling current NIMHD awardees to add practical, evidence-backed vaccination demonstration activities to their active projects.
FAQs: Evidence based Demonstration Projects in Immunization (Admin Supp) (PA-13-226)
What is PA-13-226?
PA-13-226, titled "Evidence based Demonstration Projects in Immunization (Admin Supp)," was a discretionary NIH funding announcement led by the National Institute on Minority Health and Health Disparities (NIMHD) in partnership with the National Vaccine Program Office (NVPO) within the U.S. Department of Health and Human Services.
Is this a stand-alone grant or a supplement?
This opportunity was structured as an administrative supplement. It was not a stand-alone new grant competition. It provided additional targeted funds to certain active NIMHD-supported awards so recipients could add a focused immunization demonstration project onto an existing research or center infrastructure.
What was the main purpose of this supplement?
The central purpose was to support evidence-based demonstration projects aimed at reducing infectious diseases by increasing immunization rates, with a focus on practical, real-world implementation to improve vaccination uptake in health disparity populations.
What outcomes or impacts was the program trying to achieve?
The intent was to stimulate measurable improvements in immunization coverage among children, adolescents, pregnant women, and adults, particularly in communities experiencing persistent vaccination gaps and disproportionate burdens of disease.
What kinds of projects did the announcement emphasize?
The announcement emphasized demonstration projects that translate known effective immunization approaches into real-world implementations. The framing suggests feasibility, uptake, and practical impact in specific settings or populations rather than purely exploratory research.
What does "evidence-based" mean in the context of this opportunity?
"Evidence-based" indicated applicants were expected to use strategies supported by existing research or prior successful use, and then adapt and apply those strategies to the realities and barriers affecting health disparity populations.
Which populations were the focus of these immunization efforts?
The populations of interest were health disparity populations. The opportunity was designed to help address immunization gaps affecting groups that experience disproportionate disease burden and barriers to preventive care.
Who was eligible to apply?
Eligibility was primarily tied to having an active NIMHD-supported award that could receive an administrative supplement. The practical requirement was that the applicant already held an eligible, currently funded NIMHD project or center award targeted by the announcement.
Which specific NIMHD awards were targeted for supplementation?
The announcement targeted current NIMHD R01 grantees and awardees funded under several NIMHD center or infrastructure programs: Centers of Excellence (COE) awards using P20 or P60 mechanisms, Research Centers in Minority Institutions (RCMI) awards using G12 or U54 mechanisms, and the Community Based Participatory Research Initiative using the R24 mechanism.
Do general organization types listed in Grants.gov automatically qualify an applicant?
No. While many organization types may be listed in general eligibility language (for example, universities, nonprofits, governments, tribal entities, and small businesses), this opportunity specifically functioned as an administrative supplement. The key gatekeeper was having an eligible, active NIMHD award that could be supplemented under this notice.
Were foreign institutions eligible?
No. Foreign institutions were not eligible under this announcement.
Were foreign components allowed on an otherwise eligible application?
No. Foreign components were not allowed.
Were non-U.S. components of U.S. organizations eligible?
No. Non-U.S. components of U.S. organizations were also not eligible under the stated restrictions.
What was the maximum award amount?
The supplement had an award ceiling of $100,000.
Was cost sharing or matching required?
No. The opportunity did not require cost sharing or matching.
What was the funding instrument type?
The funding instrument type was a grant, issued as an administrative supplement to an existing eligible award.
What federal program listing (CFDA) was associated with this opportunity?
The opportunity was associated with CFDA 93.307 (Minority Health and Health Disparities Research).
What topic area did this funding fall under?
The overall category was health, with a specific focus on immunization rate improvements to reduce infectious diseases in health disparity populations.
When was the opportunity posted and when did it close?
The opportunity was posted on May 16, 2013, and the application closing date was July 10, 2013.
Is this opportunity still open?
No. It was archived on August 10, 2013, indicating it was a time-limited administrative supplement initiative rather than an ongoing program.
What was the expected implementation approach for funded teams?
The announcement signaled an expectation that teams would leverage existing NIMHD-supported research capacity and community relationships to execute targeted immunization improvement efforts within real community or healthcare settings.
What barriers or challenges were applicants expected to consider?
The description highlights barriers often faced by health disparity populations, such as access challenges, trust and communication gaps, system navigation difficulties, and resource limitations in certain communities, and suggests projects should adapt evidence-based strategies to address these realities.
Where was the official notice hosted?
The official NIH announcement link was hosted on the NIH Grants Guide.
Who was listed for technical support with access or linking issues?
Technical access and linking issues were routed through the NIH Office of Extramural Research (OER) webmaster.
Which federal entities led and partnered on this opportunity?
NIMHD led the opportunity, and it was developed in partnership with the National Vaccine Program Office (NVPO) within the U.S. Department of Health and Human Services.
Browse more opportunities from the same category: Health
Next opportunity: National Park Service Research Center Support, 2013
Previous opportunity: Propagation of Rio Grande Silvery Minnow
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PA 13 226
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PA 13 226) also looked into and applied for these:
| Funding Opportunity |
|---|
| Minority Serving Institutions (MSIs) Partnerships with Community Based Organizations (CBOs). (Short Title MSI/CBO) Apply for SP 13 006 Funding Number: SP 13 006 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $300,000 |
| Rural Access to Emergency Devices Grant Program Apply for HRSA 13 280 Funding Number: HRSA 13 280 Agency: Health Resources and Services Administration Category: Health Funding Amount: $200,000 |
| National Public Health Practice and Resource Centers for Children with Attention Deficit/Hyperactivity Disorder or Tourette Syndrome Apply for CDC RFA DD13 1302 Funding Number: CDC RFA DD13 1302 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $800,000 |
| Innovative Approaches and Technologies for Examining the Uncultivable Bacteria of the Oral Microbiota (R01) Apply for RFA DE 14 003 Funding Number: RFA DE 14 003 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Building and Supporting Core Public Health Capacities Related to Violence and Injury Prevention Apply for CDC RFA CE13 1307 Funding Number: CDC RFA CE13 1307 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $500,000 |
| Children s Hospitals Graduate Medical Education (CHGME) Payment Program Apply for HRSA 14 010 Funding Number: HRSA 14 010 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| HEALTH SYSTEMS STRENGTHENING, QUALITY IMPROVEMENT, AND RMNCH A SCALE UP Apply for APS 386 13 000006 Funding Number: APS 386 13 000006 Agency: India USAID New Delhi Category: Health Funding Amount: $74,000,000 |
| Social Health Protection Project Apply for RFA 442 13 000002 Funding Number: RFA 442 13 000002 Agency: Cambodia USAID Phnom Penh Category: Health Funding Amount: $14,000,000 |
| Health Information Policy and Advocacy Project Apply for RFA 442 13 000003 Funding Number: RFA 442 13 000003 Agency: Cambodia USAID Phnom Penh Category: Health Funding Amount: $5,000,000 |
| National Support to Enhance Implementation of Comprehensive Cancer Control Activities Apply for CDC RFA DP13 1315 Funding Number: CDC RFA DP13 1315 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,000,000 |
| Using New Media to Prevent Substance Abuse and HIV/AIDS for Populations at High Risk (Short Title SA HIV/AIDS Prevention New Media) Apply for SP 13 008 Funding Number: SP 13 008 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $125,000 |
| Safe Schools/Healthy Students State Planning, Local Education Agency, and Local Community Cooperative Agreements, (Short Title SS/HS State Program) Apply for SM 13 006 Funding Number: SM 13 006 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $2,214,000 |
| National Resource Center for Mental Health Promotion and Youth Violence Prevention (Short Title YVP RC) Apply for SM 13 007 Funding Number: SM 13 007 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $6,171,000 |
| Consortium of National Networks to Impact Tobacco Related and Cancer Health Disparities Apply for CDC RFA DP13 1314 Funding Number: CDC RFA DP13 1314 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $725,000 |
| Services Research for Autism Spectrum Disorder across the Lifespan (ServASD) Pilot Research on Services for Transition Age Youth (R34) Apply for RFA MH 14 101 Funding Number: RFA MH 14 101 Agency: National Institutes of Health Category: Health Funding Amount: $225,000 |
| Services Research for Autism Spectrum Disorder across the Lifespan (ServASD) Research on Early Identification and Linkage to Services for ASD (R01) Apply for RFA MH 14 100 Funding Number: RFA MH 14 100 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Services Research for Autism Spectrum Disorders across the Lifespan (ServASD) Pilot Studies of Services Strategies for Adults with ASD (R34) Apply for RFA MH 14 102 Funding Number: RFA MH 14 102 Agency: National Institutes of Health Category: Health Funding Amount: $225,000 |
| Research Grants Using the Resources from the Osteoarthritis Initiative (OAI)(R21) Apply for PA 13 237 Funding Number: PA 13 237 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Research Grants Using the Resources from the Osteoarthritis Initiative (OAI) (R01) Apply for PA 13 236 Funding Number: PA 13 236 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Limited Competition Centers of Biomedical Research Excellence (COBRE) Phase III Transitional Centers P30 Apply for PAR 13 238 Funding Number: PAR 13 238 Agency: National Institutes of Health Category: Health Funding Amount: $750,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PA 13 226", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.